Middle East & Africa Continuous Glucose Monitoring Devices Market (2025 - 2033) Size, Share & Trends Analysis Report By Type (Appliers, Accessories), By Connectivity, By Indication, By End Use, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                        1.2.1. Type Segment
                        1.2.2. Connectivity Segment
                        1.2.3. Indication Segment
                        1.2.4. End-use Segment
                    1.3. Information analysis
                        1.3.1. Market formulation & data visualization
                    1.4. Data validation & publishing
                    1.5. Information Procurement
                        1.5.1. Primary Research
                    1.6. Information or Data Analysis
                    1.7. Market Formulation & Validation
                    1.8. Market Model
                    1.9. Total Market: CAGR Calculation
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights Landscape
Chapter 3. Middle East & Africa Continuous Glucose Monitoring Devices Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. Middle East & Africa Continuous Glucose Monitoring Devices Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                        3.3.2. PESTEL Analysis
Chapter 4. Middle East & Africa Continuous Glucose Monitoring Devices Market: Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Middle East & Africa Continuous Glucose Monitoring Devices Market Type Movement Analysis
                    4.3. Middle East & Africa Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Device Type, 2021 to 2033 (USD Million)
                    4.4. Standalone CGM Devices
                        4.4.1. Standalone CGM Devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
                    4.5. Integrated CGM-Insulin Pump Systems
                        4.5.1. Integrated CGM-Insulin Pump Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East & Africa Continuous Glucose Monitoring Devices Market: Connectivity Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Middle East & Africa Continuous Glucose Monitoring Devices Market Connectivity Movement Analysis
                    5.3. Middle East & Africa Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
                    5.4. Bluetooth
                        5.4.1. Bluetooth market revenue estimates and forecasts, 2021 - 2033 (USD Million)
                    5.5. 4G/Cellular
                        5.5.1. 4G/Cellular market revenue estimates and forecasts, 2021 - 2033 (USD Million)
                    5.6. NFC (Near Field Communication)
                        5.6.1. NFC (Near Field Communication) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East & Africa Continuous Glucose Monitoring Devices Market: Indication Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Middle East & Africa Continuous Glucose Monitoring Devices Market Indication Movement Analysis
                    6.3. Middle East & Africa Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Patient Type, 2021 to 2033 (USD Million)
                    6.4. Type 1 Diabetes
                        6.4.1. Type 1 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
                    6.5. Type 2 Diabetes
                        6.5.1. Type 2 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East & Africa Continuous Glucose Monitoring Devices Market: End Use Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Middle East & Africa Continuous Glucose Monitoring Devices Market End Use Movement Analysis
                    7.3. Middle East & Africa Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    7.4. Hospitals & Clinics
                        7.4.1. Hospitals & Clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
                    7.5. Homecare / Personal Use
                        7.5.1. Homecare / Personal Use market revenue estimates and forecasts, 2021 - 2033 (USD Million)
                    7.6. Others
                        7.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Middle East & Africa Continuous Glucose Monitoring Devices Market: Regional Estimates & Trend Analysis
                    8.1. Regional Dashboard
                    8.2. Regional Middle East & Africa Continuous Glucose Monitoring Devices Market movement analysis
                    8.3. Middle East & Africa Continuous Glucose Monitoring Devices Market: Regional Estimates & Trend Analysis by Technology & End-use
                    8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
                        8.4.1. Middle East & Africa
                        8.4.2. Middle East & Africa Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        8.4.3. South Africa
                            8.4.3.1. Key Country Dynamics
                            8.4.3.2. Competitive Scenario
                            8.4.3.3. Regulatory Framework
                            8.4.3.4. Reimbursement scenario
                            8.4.3.5. South Africa Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        8.4.4. Saudi Arabia
                            8.4.4.1. Key Country Dynamics
                            8.4.4.2. Competitive Scenario
                            8.4.4.3. Regulatory Framework
                            8.4.4.4. Reimbursement scenario
                            8.4.4.5. Saudi Arabia Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        8.4.5. UAE
                            8.4.5.1. Key Country Dynamics
                            8.4.5.2. Competitive Scenario
                            8.4.5.3. Regulatory Framework
                            8.4.5.4. Reimbursement scenario
                            8.4.5.5. UAE Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        8.4.6. Kuwait
                            8.4.6.1. Key Country Dynamics
                            8.4.6.2. Competitive Scenario
                            8.4.6.3. Regulatory Framework
                            8.4.6.4. Reimbursement scenario
                            8.4.6.5. Kuwait Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Company/Competition Categorization
                    9.2. Strategy Mapping
                    9.3. Company Market Position Analysis, 2024
                    9.4. Company Profiles/Listing
                        9.4.1. Dexcom, Inc
                            9.4.1.1. Company overview
                            9.4.1.2. Financial performance
                            9.4.1.3. Product benchmarking
                            9.4.1.4. Strategic initiatives
                        9.4.2. Abbott Laboratories
                            9.4.2.1. Company overview
                            9.4.2.2. Financial performance
                            9.4.2.3. Product benchmarking
                            9.4.2.4. Strategic initiatives
                        9.4.3. Medtronic plc
                            9.4.3.1. Company overview
                            9.4.3.2. Financial performance
                            9.4.3.3. Product benchmarking
                            9.4.3.4. Strategic initiatives
                        9.4.4. Senseonics Holdings, Inc
                            9.4.4.1. Company overview
                            9.4.4.2. Financial performance
                            9.4.4.3. Product benchmarking
                            9.4.4.4. Strategic initiatives
                        9.4.5. F. Hoffmann-La Roche (Roche Diabetes Care)
                            9.4.5.1. Company overview
                            9.4.5.2. Financial performance
                            9.4.5.3. Product benchmarking
                            9.4.5.4. Strategic initiatives
                        9.4.6. Ypsomed AG
                            9.4.6.1. Company overview
                            9.4.6.2. Financial performance
                            9.4.6.3. Product benchmarking
                            9.4.6.4. Strategic initiatives
                        9.4.7. GlySens Incorporated
                            9.4.7.1. Company overview
                            9.4.7.2. Financial performance
                            9.4.7.3. Product benchmarking
                            9.4.7.4. Strategic initiatives
                        9.4.8. Novo Nordisk A/S
                            9.4.8.1. Company overview
                            9.4.8.2. Financial performance
                            9.4.8.3. Product benchmarking
                            9.4.8.4. Strategic initiatives
                        9.4.9. Ascensia Diabetes Care
                            9.4.9.1. Company overview
                            9.4.9.2. Financial performance
                            9.4.9.3. Product benchmarking
                            9.4.9.4. Strategic initiatives
                        9.4.10. Diabetes Cloud (Aidex) and Meiqi (emerging startups)
                            9.4.10.1. Company overview
                            9.4.10.2. Financial performance
                            9.4.10.3. Product benchmarking
                            9.4.10.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Middle East & Africa Continuous Glucose Monitoring Devices Market by Country, 2021 - 2033 (USD Million)
Table 4 Middle East & Africa Continuous Glucose Monitoring Devices Market by Type, 2021 - 2033 (USD Million)
Table 5 Middle East & Africa Continuous Glucose Monitoring Devices Market by Connectivity, 2021 - 2033 (USD Million)
Table 6 Middle East & Africa Continuous Glucose Monitoring Devices Market by Indication, 2021 - 2033 (USD Million)
Table 7 Middle East & Africa Continuous Glucose Monitoring Devices Market by End use, 2021 - 2033 (USD Million)
Table 8 South Africa Continuous Glucose Monitoring Devices Market by Type, 2021 - 2033 (USD Million)
Table 9 South Africa Continuous Glucose Monitoring Devices Market by Connectivity, 2021 - 2033 (USD Million)
Table 10 South Africa Continuous Glucose Monitoring Devices Market by Indication, 2021 - 2033 (USD Million)
Table 11 South Africa Continuous Glucose Monitoring Devices Market by End use, 2021 - 2033 (USD Million)
Table 12 Saudi Arabia Continuous Glucose Monitoring Devices Market by Type, 2021 - 2033 (USD Million)
Table 13 Saudi Arabia Continuous Glucose Monitoring Devices Market by Connectivity, 2021 - 2033 (USD Million)
Table 14 Saudi Arabia Continuous Glucose Monitoring Devices Market by Indication, 2021 - 2033 (USD Million)
Table 15 Saudi Arabia Continuous Glucose Monitoring Devices Market by End use, 2021 - 2033 (USD Million)
Table 16 UAE Continuous Glucose Monitoring Devices Market by Type, 2021 - 2033 (USD Million)
Table 17 UAE Continuous Glucose Monitoring Devices Market by Connectivity, 2021 - 2033 (USD Million)
Table 18 UAE Continuous Glucose Monitoring Devices Market by Indication, 2021 - 2033 (USD Million)
Table 19 UAE Continuous Glucose Monitoring Devices Market by End use, 2021 - 2033 (USD Million)
Table 20 Kuwait Continuous Glucose Monitoring Devices Market by Type, 2021 - 2033 (USD Million)
Table 21 Kuwait Continuous Glucose Monitoring Devices Market by Connectivity, 2021 - 2033 (USD Million)
Table 22 Kuwait Continuous Glucose Monitoring Devices Market by Indication, 2021 - 2033 (USD Million)
Table 23 Kuwait Continuous Glucose Monitoring Devices Market by End use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Europe orthokeratology lens market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Middle East & Africa CGM devices market, type outlook key takeaways (USD Million)
Fig. 12 Middle East & Africa CGM devices market type movement analysis 2024 & 2033 (USD Million)
Fig. 13 Standalone CGM devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 14 Integrated CGM-insulin pump systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 15 Middle East & Africa CGM devices market, connectivity outlook key takeaways (USD Million)
Fig. 16 Middle East & Africa CGM devices market connectivity movement analysis 2024 & 2033 (USD Million)
Fig. 17 Bluetooth market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 18 4G/Cellular market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 19 NFC (Near Field Communication) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Middle East & Africa CGM devices market, indication outlook key takeaways (USD Million)
Fig. 21 Middle East & Africa CGM devices market indication movement analysis 2024 & 2033 (USD Million)
Fig. 22 Type 1 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Type 2 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Middle East & Africa CGM devices market, end-use outlook key takeaways (USD Million)
Fig. 25 Middle East & Africa CGM devices market end-use movement analysis 2024 & 2033 (USD Million)
Fig. 26 Hospitals & clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Homecare / personal use market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Middle East & Africa CGM devices market, regional key takeaways (USD Million)
Fig. 30 Middle East & Africa CGM devices market regional outlook, 2024 & 2033
Fig. 31 Middle East & Africa CGM devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 South Africa CGM devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Saudi Arabia CGM devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 UAE CGM devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Kuwait CGM devices market estimates and forecasts, 2021 - 2033 (USD Million)